FDA: FDA approves new drug to treat heart failure
16.07.2015
The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related to heart failure.
Źródło wiadomośći: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm453845.htm
SciencePharma
